Combining the action of medicines with personalized
digital treatment to develop digital combination drugs.
Dr.SAM conversations follow symptoms, daily habits and changes after medication.
Accumulated records are organized into a report.
Development concept · Example screens
Ask about symptoms and habits, then follow changes after medication.
I have a bad headache today.
How did you sleep last night?
I was up late working.
Lack of sleep can cause headaches — I’ll note that.
I took my prescription for the headache.
It’s been two hours since your dose — how are you feeling now?
Organize symptoms, habits and medication records from the conversation.
Changes after medication are checked in the follow-up conversation.
Review symptom trends and changes after medication through accumulated records.
Changes after medication are checked in the follow-up conversation.
For treatments that combine medicines and digital technology,
Korea has established a legal framework, while the US is outlining its regulatory approach.
The Act defines digital combination drugs as a product category and establishes a framework for their development, authorization and evaluation.
Read the ActPrescription Drug Use-Related Software
The FDA draft describes how drug-labeling authorities would apply to certain outputs of software used with prescription drugs.
Read FDA draft guidanceFrom differentiating existing medicines to building new pipelines,
partner with DrugOS™.
Exploring Hybrid Drugs that combine medicines with digital treatment protocols
Official announcementLilly Health launched for users of Zepbound and Mounjaro
Official announcementRejoyn, a prescription digital therapeutic used alongside antidepressant treatment
Official announcement